Global obesity is on the rise, and endocrinologists are at the forefront of diagnosing its underlying causes and prescribing treatment plans. The Society works to reduce prevalence of obesity through various means, including development and release of scientific statements and practice guidelines, and advocacy for policies and positions that ensure access to affordable treatments. As new obesity medications come to market, the Society will play an important role in educating providers and patients on their optimal usage.
The Endocrine Society is working on a new Clinical Practice Guideline (CPG) for the treatment of obesity that is schedule for release in MONTH. View our existing CPGs on obesity treatment.
Daniel Drucker, MD, shares his story as one of the first researchers to discover GLP-1s for treating diabetes and obesity in a new video series on obesity care. View other obesity-related videos.
